SciELO - Scientific Electronic Library Online

 
vol.22 issue1Impacto de los eventos de El Niño Southern oscillation (ENSO) sobre la leishmaniosis cutánea en Sucre, Venezuela, a través del uso de información satelital, 1994 - 2003Oportunidad en el diagnóstico y tratamiento de la malaria en comunidades periurbanas de la amazonía peruana author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Peruana de Medicina Experimental y Salud Publica

Print version ISSN 1726-4634

Abstract

GALLEGOS V, Karen; BALDEVIANO V, Christian; MARCELO N, Adolfo  and  PADILLA R, Carlos. Clonamiento, expresión y seroreactividad del antígeno recombinante flagelina de Bartonella bacilliformis. Rev. perú. med. exp. salud publica [online]. 2005, vol.22, n.1, pp.39-46. ISSN 1726-4634.

Objectives: To clone the Bartonella bacilliformis flagellin gene (flaA), and to preliminarily express and assess reactivity of the recombinant protein against B. bacilliformis bartonellosis patients' sera. Materials and Methods: A couple of initiating oligonucleotides was designed -BbFlaA1 and BbFlaA2- for complete B. bacilliformis flagelline A gene amplification. The amplification product obtained was cloned in pEGM, and later it was subcloned in pGEX4T-1 expression vector. Fusion protein rBbFlaA-GST expression was induced with isopropyl thio-β -D-galactoside (IPTG). The fusion protein produced was digested with thrombin in order to release its GST contents. Finally, an ELISA test was standardized in order to detect IgG antibodies against fusion protein rBbFlaA-GST and rBbflaA GST-free. Sera from patients with bartonellosis caused by B. bacilliformis (n= 30), sera from healthy individuals (n= 20), and sera from patients with a possible cross-reactivity; i.e., brucellosis (n= 3), leptospirosis (n= 3), and salmonellosis (n= 7) were assessed. Results: It was determined that for optimal expression of fusion protein rBbFlaA in E. coli BL21, it is required that the culture grows in LB/ampicillin broth at a 30º C temperature, supplemented with 2% glucose from a 100 µL pre-inoculum (left to grow overnight), until it reaches a 1 optical density (OD 600), and being induced for two hours at 2,5 mM IPTG. Finally, 57,6% (17 of 30) sera from patients with a confirmed bartonellosis diagnosis reacted with BbFlaA recombinant protein in an ELISA format. Conclusions: B. bacilliformis BbFlaA recombinant protein was successfully expressed in E. coli, and an rBbFlaA expression and purification protocol was determined for producing this protein. Also, rBbFlaA antigen is recognized by antibodies present in sera from bartonellosis patients infected with B. bacilliformis.

Keywords : Bartonella bacilliformis; Diagnosis; Flagellin; Enzime-Lynked Immunosorbent Assay; Recombinant Proteins; Carrion's Diseases.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License